http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2268471-C2
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
filingDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c3842f93fe90cbe514016d82253f06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ff393385bc600bb052610017b1e1e9 |
publicationDate | 2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2268471-C2 |
titleOfInvention | Method for detecting immunoreactive compounds |
abstract | FIELD: immunology. n SUBSTANCE: the present innovation deals with one-stage detection of a bound analyte with a conjugate consisted of an analyte-stereospecific compound (anti-analyte) being covalently conjugated with suspensoid particles of water-insoluble dyestuffs, as coumassi R-250, and/or acridine yellow, and/or acridine orange, and/or 2.4-nitrodiphenyl hydrazine, and/or fluorescein. Application of an anti-analyte with a colored suspensoid label in technology for obtaining conjugates for analysis of one-stage covalent binding leads to considerable simplification of synthesis procedure, increased economy, and reproducibility and higher sensitivity of detection systems. Thus, the innovation enables to improve sensitivity and reliability of stereospecific analysis and optimization of technology to obtain reagents applied in this process being necessary for detection (stereospecific conjugates). n EFFECT: higher accuracy of detection. n 5 ex |
priorityDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.